An Exploration of Simulated Presence Therapy as a Formulation Based Intervention for Dementia Related Distress.
NCT ID: NCT04876911
Last Updated: 2021-05-18
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
13 participants
Study Classification
INTERVENTIONAL
Study Start Date
2021-06-01
Study Completion Date
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is known that persons with a diagnosis of dementia can experience distress associated with the condition. There are different ways that distress is expressed between these persons, but some common occurrences include physical or verbal aggression, tearfulness, upset, confusion and asking repetitive questions. Medications have typically dominated management of symptoms of distress in dementia, and whilst effective, can result in other problems, such as dependency and reduced effectiveness over time. Non-medical interventions may help to reduce distress without the pitfalls of medications. One such intervention is Simulated Presence Therapy.
Simulated Presence Therapy involves playing an audio and/or visual recording with a comforting message from a loved one to a person with dementia to reduce distress. At present, there are few studies examining its effectiveness, with some indication that Simulated Presence Therapy can benefit some people, but this outcome is not consistent. One reason for this may be due to the focus on diagnosis and symptoms in previous studies rather than 'formulation'. Formulation is an approach to healthcare that attempts to arrive at an understanding of a patient's concern(s), taking into account the views of the patient, their loved ones and other healthcare professionals, as well as psychological theory and research evidence.
This study aims to determine if Simulated Presence Therapy delivered via an iPad, when used within a formulation, reduces distress in patients with moderate to severe dementia admitted for long-term care in a care home or inpatient hospital ward. This study will also examine how user-friendly and helpful Simulated Presence Therapy was for healthcare professionals who administer it. Participants may not have the ability to provide consent; therefore, this will be obtained from the legal guardian or next of kin.
All participants will have received a formulation that identifies Simulated Presence Therapy as the preferred intervention. Their occurrence will be counted on a chart and tallied each day before and after the intervention is introduced. The healthcare staff who administer Simulated Presence Therapy will complete a questionnaire to evaluate their opinions on its user-friendliness and effectiveness. It is hoped that this study may enable service providers to better understand how to integrate Simulated Presence Therapy into healthcare services for persons with a diagnosis of dementia.
Simulated Presence Therapy involves playing an audio and/or visual recording with a comforting message from a loved one to a person with dementia to reduce distress. At present, there are few studies examining its effectiveness, with some indication that Simulated Presence Therapy can benefit some people, but this outcome is not consistent. One reason for this may be due to the focus on diagnosis and symptoms in previous studies rather than 'formulation'. Formulation is an approach to healthcare that attempts to arrive at an understanding of a patient's concern(s), taking into account the views of the patient, their loved ones and other healthcare professionals, as well as psychological theory and research evidence.
This study aims to determine if Simulated Presence Therapy delivered via an iPad, when used within a formulation, reduces distress in patients with moderate to severe dementia admitted for long-term care in a care home or inpatient hospital ward. This study will also examine how user-friendly and helpful Simulated Presence Therapy was for healthcare professionals who administer it. Participants may not have the ability to provide consent; therefore, this will be obtained from the legal guardian or next of kin.
All participants will have received a formulation that identifies Simulated Presence Therapy as the preferred intervention. Their occurrence will be counted on a chart and tallied each day before and after the intervention is introduced. The healthcare staff who administer Simulated Presence Therapy will complete a questionnaire to evaluate their opinions on its user-friendliness and effectiveness. It is hoped that this study may enable service providers to better understand how to integrate Simulated Presence Therapy into healthcare services for persons with a diagnosis of dementia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
NCT05860127
Dementia
Cognitive Impairment, Mild
Dementia, Vascular
+6 more
ACTIVE_NOT_RECRUITING
NA
Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers
NCT01273272
Alzheimer Disease
COMPLETED
PHASE2
Cognitive Stimulation Therapy for Residents With Dementia in Nursing Homes
NCT06978972
Dementia in Nursing Home
COMPLETED
NA
Multisensory Stimulation in Dementia.
NCT04008342
Dementia
COMPLETED
NA
Group CST Using Zoom: A Proof of Concept Study
NCT04695743
Dementia
UNKNOWN
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background: Persons with dementia (PwD) often present with a cluster of signs or symptoms of distorted perceptions, thoughts, mood and behaviours, commonly referred to as the behavioural and psychological symptoms of dementia. Psychosocial conceptualisations posit that these symptoms manifest as a result of distress arising from an unmet need; thus, the term 'stressed and distressed behaviours' (SDB) may more accurately represent the aetiology of these symptoms. This ethos has been aggregated into the Newcastle model, first conceptualised by Dr Ian James and his colleagues, which emphasises a formulation-based approach to dementia care. Formulation refers to the process of collaboratively developing a hypothesis regarding an individual's difficulties by incorporating psychological theory and evidence.
Although formulation-based approaches are become more widespread, prescribing practices for medical treatments remains suboptimal across dementia care settings. Considering the personal, societal and economic burdens of SDB in PwD, coupled with the disadvantages of pharmacological interventions, there remains a real need to develop effective non-pharmacological, psychosocial alternatives. One such intervention is Simulated Presence Therapy (SPT).
SPT is an intervention that involves playing a video and/or audio recording of a loved one to a PwD with a reassuring message when they present with SDB. Studies examining the efficacy of SPT are sparse; however, what little research that has been conducted has highlighted its effectiveness in some instances. Thus far, studies have not explored SPT when it has been identified as a way of addressing an unmet need through a formulation-driven assessment process. Instead, it has been applied to participants within specific care settings with a symptom rather than formulation-based approach. Hence, this study will explore the efficacy of SPT as part of a formulation-driven approach, grounded in the Newcastle model.
Aim/objectives (s): The present study will aim to investigate the efficacy of SPT for SDB in PwD when it has been specifically identified via a Newcastle formulation as the preferred intervention within care homes and hospital wards operated by the National Health Service of Greater Glasgow and Clyde (NHSGGC) and their associated Health and Social Care Partnerships (HSCP). The research is being conducted to fulfil part of the requirements of the Principal Investigator's Doctorate in Clinical Psychology Qualification at the University of Glasgow, and the University will therefore be an additional collaborating organisation. In terms of objectives:
* Primary Objective - Introduction of SPT will significantly reduce SDB during day-to-day activities when compared to activities without SPT.
* Secondary Objective - What is the acceptability of SPT amongst healthcare professionals that administer it?
Design: This study will employ a randomised single case experimental design (SCED) of two phases (i.e. AB) with multiple baselines. This which would involve randomly allocating PwD to a staggered baseline period (A), followed by the intervention phase (B), which would last as long as the corresponding baseline phase.
Sample: Owing to the fact that, whilst the PwD are the participants that will form the key group to answer the research question, from a technical perspective, the sample consists of multiple categories of persons. For clarity, the following terms are employed:
1. 'Participants' will refer to the PwD recruited to receive SPT.
2. 'Informants' will refer to the person who complete the two attachment/relationship questionnaires for the participant.
3. 'Recorders' will refer to non-healthcare professionals, such as family members or friends, who agree to be filmed for the SPT video.
4. 'Professionals' will refer to the care staff involved in the PwD's care who complete the staff user-experience questionnaire within this study.
5. 'Sample' will refer to all persons participating in the study (i.e. Participants, Informants, Recorders and Professionals).
The anticipated minimum sample size is 13, consisting of participants (N = 6), informants/recorders (N = 6) and professional(s) (N = 1). Recruitment will be from identified care homes and hospital wards that receive input from NHSGGC's Older Person Psychology Service (OPPS).
Measure(s):
* Dementia Severity Rating Scale (DSRS) - This is a validated multiple-choice, informant-based questionnaire, designed to categorise the severity of a patient's dementia. These categories are 'mild', 'moderate' or 'severe'.
* Measure of Attachment Adapted (MOA) - This is a measure of attachment that has been adapted by the Principal Investigator for use in the present study and to be answered by informants. Informants are asked to read three paragraphs and asked to tick which one they feel best describes the patient. There are two sections of the measure: (1) One for if the informant has known the patient before they received their diagnosis of dementia, and (2) another for if the informant knew the patient ONLY after they received a diagnosis. The informant needs to only complete one of these sections. Attachment style can then be categorised as 'secure', 'avoidant' or 'anxious/ambivalent'.
* Measure of Attachment Qualities Adapted (MAQ) - This is a multiple-choice, Likert-scale measure of attachment that has been adapted by the Principal Investigator for use in the present study and to be answered by informants. There are two sections of the measure: (1) One for if the informant has known the patient before they received their diagnosis of dementia, and (2) another for if the informant knew the patient ONLY after they received a diagnosis. The informant needs to only complete one of these sections. Attachment style can then be categorised as 'secure', 'avoidant', 'ambivalent-worry' or 'ambivalent-merger'.
* Unified Theory of Acceptance and Use of Technology (UTAT)-informed Questionnaire - This is a self-report, Likert scale questionnaire developed by the Principal Investigator based on the UTAT. The measure consists of a series of statements pertaining to the usefulness and effectiveness of SPT with respondents who administered SPT selecting how strongly they agree/disagree with each. Higher scores are indicative of greater usefulness, acceptability and/or effectiveness.
* Frequency Chart - This is a chart which is used to tally the number of dSDB exhibited by patients within a specific time period and day. These recordings are made by healthcare staff who work directly with a patient.
Procedures: The process for recruitment is as follows: where capacity to consent is retained, this will be sought from the participant; where the participant is deemed to not have capacity to consent, informed consent for will be obtained from the relevant legal guardian/next of kin; informed consent for those persons who are not healthcare professionals, but complete questionnaires and record videos for the participants, will also be obtained with regard to inclusion of their responses within the present study. Informed consent for the staff UTAT-informed questionnaire will also be obtained.
Following the recruitment process, arrangements to obtain recordings and complete the MOA and MAQ will be established collaboratively between the person recorded and NHSGGC OPPS. All participants will have already received a Newcastle formulation as part of routine care and will be randomly allocated to randomly allocated to a 14, 17 or 21-day baseline period where dSDB is tallied. Immediately once the baseline phase has concluded, the intervention phase will commence, which will last indefinitely for the participants for whom SPT is an effective intervention, although the data that will be extracted at intervention stage will be at least the length of the baseline.
The UTAT-informed questionnaire would be disseminated to professionals near the conclusion of the data collection stage.
Data Analysis: Data analysis for evaluating intervention effects in SCEDs encompasses visual inspection and statistical analysis. Visual analysis involves examining level, trend, variability, immediacy of effect, overlap, and consistency of data patterns within and between phases. Statistical analysis will involve calculation of a Baseline Corrected Tau (BC-Tau) to measure data non-overlap between the two phases (A and B). Non-overlapping data as an indicator of performance difference between phases is included in standards for evaluating SCEDs. Additionally, BC-Tau is useful in aggregating data across phases to produce an overall effect size.
Evaluation of the secondary objective will involve calculating the average score across participants on the UTAT informed questionnaire, with a higher score indicative of greater acceptability.
Ethics and safety: A number of safeguards are in place regarding sample and researcher safety with relevant policies and legislation consulted in the construction of this project. These are detailed in full within the uploaded research protocol. Applications/approvals will be sought by an Ethics committee and NHSGGC's Research and Innovation department. Approval to proceed to ethics for this project has been obtained from the University of Glasgow.
Timetable:
* May/June 2021: Ethics submission.
* June/July 2021 - December 2021: Recruitment and data collection.
* January 2022: End of data collection, data analysis and write-up.
* February-April 2022: Final report article generated.
Dissemination/application: The results of this study will provide insight into the efficacy of SPT when used as part of a formulation-driven approach to dementia care. It is anticipated that this information will enable service providers to understand how to integrate SPT in services and care pathways for PwD. Dissemination will occur once the final research article has been generated by the Principal Investigator, which will be made available on the University of Glasgow's Enlighten thesis repository for public domain access in PDF format, and possibly in a paper that will be submitted for publication.
Although formulation-based approaches are become more widespread, prescribing practices for medical treatments remains suboptimal across dementia care settings. Considering the personal, societal and economic burdens of SDB in PwD, coupled with the disadvantages of pharmacological interventions, there remains a real need to develop effective non-pharmacological, psychosocial alternatives. One such intervention is Simulated Presence Therapy (SPT).
SPT is an intervention that involves playing a video and/or audio recording of a loved one to a PwD with a reassuring message when they present with SDB. Studies examining the efficacy of SPT are sparse; however, what little research that has been conducted has highlighted its effectiveness in some instances. Thus far, studies have not explored SPT when it has been identified as a way of addressing an unmet need through a formulation-driven assessment process. Instead, it has been applied to participants within specific care settings with a symptom rather than formulation-based approach. Hence, this study will explore the efficacy of SPT as part of a formulation-driven approach, grounded in the Newcastle model.
Aim/objectives (s): The present study will aim to investigate the efficacy of SPT for SDB in PwD when it has been specifically identified via a Newcastle formulation as the preferred intervention within care homes and hospital wards operated by the National Health Service of Greater Glasgow and Clyde (NHSGGC) and their associated Health and Social Care Partnerships (HSCP). The research is being conducted to fulfil part of the requirements of the Principal Investigator's Doctorate in Clinical Psychology Qualification at the University of Glasgow, and the University will therefore be an additional collaborating organisation. In terms of objectives:
* Primary Objective - Introduction of SPT will significantly reduce SDB during day-to-day activities when compared to activities without SPT.
* Secondary Objective - What is the acceptability of SPT amongst healthcare professionals that administer it?
Design: This study will employ a randomised single case experimental design (SCED) of two phases (i.e. AB) with multiple baselines. This which would involve randomly allocating PwD to a staggered baseline period (A), followed by the intervention phase (B), which would last as long as the corresponding baseline phase.
Sample: Owing to the fact that, whilst the PwD are the participants that will form the key group to answer the research question, from a technical perspective, the sample consists of multiple categories of persons. For clarity, the following terms are employed:
1. 'Participants' will refer to the PwD recruited to receive SPT.
2. 'Informants' will refer to the person who complete the two attachment/relationship questionnaires for the participant.
3. 'Recorders' will refer to non-healthcare professionals, such as family members or friends, who agree to be filmed for the SPT video.
4. 'Professionals' will refer to the care staff involved in the PwD's care who complete the staff user-experience questionnaire within this study.
5. 'Sample' will refer to all persons participating in the study (i.e. Participants, Informants, Recorders and Professionals).
The anticipated minimum sample size is 13, consisting of participants (N = 6), informants/recorders (N = 6) and professional(s) (N = 1). Recruitment will be from identified care homes and hospital wards that receive input from NHSGGC's Older Person Psychology Service (OPPS).
Measure(s):
* Dementia Severity Rating Scale (DSRS) - This is a validated multiple-choice, informant-based questionnaire, designed to categorise the severity of a patient's dementia. These categories are 'mild', 'moderate' or 'severe'.
* Measure of Attachment Adapted (MOA) - This is a measure of attachment that has been adapted by the Principal Investigator for use in the present study and to be answered by informants. Informants are asked to read three paragraphs and asked to tick which one they feel best describes the patient. There are two sections of the measure: (1) One for if the informant has known the patient before they received their diagnosis of dementia, and (2) another for if the informant knew the patient ONLY after they received a diagnosis. The informant needs to only complete one of these sections. Attachment style can then be categorised as 'secure', 'avoidant' or 'anxious/ambivalent'.
* Measure of Attachment Qualities Adapted (MAQ) - This is a multiple-choice, Likert-scale measure of attachment that has been adapted by the Principal Investigator for use in the present study and to be answered by informants. There are two sections of the measure: (1) One for if the informant has known the patient before they received their diagnosis of dementia, and (2) another for if the informant knew the patient ONLY after they received a diagnosis. The informant needs to only complete one of these sections. Attachment style can then be categorised as 'secure', 'avoidant', 'ambivalent-worry' or 'ambivalent-merger'.
* Unified Theory of Acceptance and Use of Technology (UTAT)-informed Questionnaire - This is a self-report, Likert scale questionnaire developed by the Principal Investigator based on the UTAT. The measure consists of a series of statements pertaining to the usefulness and effectiveness of SPT with respondents who administered SPT selecting how strongly they agree/disagree with each. Higher scores are indicative of greater usefulness, acceptability and/or effectiveness.
* Frequency Chart - This is a chart which is used to tally the number of dSDB exhibited by patients within a specific time period and day. These recordings are made by healthcare staff who work directly with a patient.
Procedures: The process for recruitment is as follows: where capacity to consent is retained, this will be sought from the participant; where the participant is deemed to not have capacity to consent, informed consent for will be obtained from the relevant legal guardian/next of kin; informed consent for those persons who are not healthcare professionals, but complete questionnaires and record videos for the participants, will also be obtained with regard to inclusion of their responses within the present study. Informed consent for the staff UTAT-informed questionnaire will also be obtained.
Following the recruitment process, arrangements to obtain recordings and complete the MOA and MAQ will be established collaboratively between the person recorded and NHSGGC OPPS. All participants will have already received a Newcastle formulation as part of routine care and will be randomly allocated to randomly allocated to a 14, 17 or 21-day baseline period where dSDB is tallied. Immediately once the baseline phase has concluded, the intervention phase will commence, which will last indefinitely for the participants for whom SPT is an effective intervention, although the data that will be extracted at intervention stage will be at least the length of the baseline.
The UTAT-informed questionnaire would be disseminated to professionals near the conclusion of the data collection stage.
Data Analysis: Data analysis for evaluating intervention effects in SCEDs encompasses visual inspection and statistical analysis. Visual analysis involves examining level, trend, variability, immediacy of effect, overlap, and consistency of data patterns within and between phases. Statistical analysis will involve calculation of a Baseline Corrected Tau (BC-Tau) to measure data non-overlap between the two phases (A and B). Non-overlapping data as an indicator of performance difference between phases is included in standards for evaluating SCEDs. Additionally, BC-Tau is useful in aggregating data across phases to produce an overall effect size.
Evaluation of the secondary objective will involve calculating the average score across participants on the UTAT informed questionnaire, with a higher score indicative of greater acceptability.
Ethics and safety: A number of safeguards are in place regarding sample and researcher safety with relevant policies and legislation consulted in the construction of this project. These are detailed in full within the uploaded research protocol. Applications/approvals will be sought by an Ethics committee and NHSGGC's Research and Innovation department. Approval to proceed to ethics for this project has been obtained from the University of Glasgow.
Timetable:
* May/June 2021: Ethics submission.
* June/July 2021 - December 2021: Recruitment and data collection.
* January 2022: End of data collection, data analysis and write-up.
* February-April 2022: Final report article generated.
Dissemination/application: The results of this study will provide insight into the efficacy of SPT when used as part of a formulation-driven approach to dementia care. It is anticipated that this information will enable service providers to understand how to integrate SPT in services and care pathways for PwD. Dissemination will occur once the final research article has been generated by the Principal Investigator, which will be made available on the University of Glasgow's Enlighten thesis repository for public domain access in PDF format, and possibly in a paper that will be submitted for publication.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Behavioural and Psychiatric Symptoms of Dementia
Stress, Psychological
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
SEQUENTIAL
Multiple Baseline Single Case Experimental Design (SCED) of two phases.
Primary Study Purpose
SUPPORTIVE_CARE
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control/Usual Care
No intervention delivered and care is provided as usual.
Group Type
NO_INTERVENTION
No interventions assigned to this group
Simulated Presence Therapy (SPT)
Participants begin to receive the SPT.
Group Type
EXPERIMENTAL
Simulated Presence Therapy
Intervention Type
BEHAVIORAL
A video recording of a loved one is played (via an iPad) prior to or during periods where a participant is presenting with stressed/distressed behaviours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simulated Presence Therapy
A video recording of a loved one is played (via an iPad) prior to or during periods where a participant is presenting with stressed/distressed behaviours.
Intervention Type
BEHAVIORAL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
SPT
Simulated Presence Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
For participants:
* A resident within a care home or hospital ward setting operated by NHS Greater Glasgow and Clyde and/or Glasgow City HSCP, Inverclyde HSCP and/or Renfrewshire HSCP.
* Persons aged ≥ 65 years.
* First language must be English.
* A diagnosis of any form of dementia within the moderate to severe stages, defined as a score of at least '19' on the validated Dementia Severity Rating Scale.
* Present with SDB as confirmed by a Newcastle formulation constructed by a psychologist with multidisciplinary input.
* Having retained the relevant cognitive faculties required to engage with audio-video technologies, including attention, recognition and communication as confirmed by a Newcastle formulation constructed by a clinical psychologist with multidisciplinary input.
For informants, inclusion requires proficiency in the English language and having known the participant before and/or after the participants diagnosis of dementia, as well as having interacted with the participant in any capacity over the previous year.
Finally, regarding professionals, inclusion involves proficiency in English language and being employed by NHSGGC and having worked directly on a regular basis with the participant at point of recruitment (i.e. once over the previous 3-month period).
* A resident within a care home or hospital ward setting operated by NHS Greater Glasgow and Clyde and/or Glasgow City HSCP, Inverclyde HSCP and/or Renfrewshire HSCP.
* Persons aged ≥ 65 years.
* First language must be English.
* A diagnosis of any form of dementia within the moderate to severe stages, defined as a score of at least '19' on the validated Dementia Severity Rating Scale.
* Present with SDB as confirmed by a Newcastle formulation constructed by a psychologist with multidisciplinary input.
* Having retained the relevant cognitive faculties required to engage with audio-video technologies, including attention, recognition and communication as confirmed by a Newcastle formulation constructed by a clinical psychologist with multidisciplinary input.
For informants, inclusion requires proficiency in the English language and having known the participant before and/or after the participants diagnosis of dementia, as well as having interacted with the participant in any capacity over the previous year.
Finally, regarding professionals, inclusion involves proficiency in English language and being employed by NHSGGC and having worked directly on a regular basis with the participant at point of recruitment (i.e. once over the previous 3-month period).
Exclusion Criteria
For participants:
* No relative/friend/caregiver available to be recorded.
* Significant vision and/or hearing impairments that cannot be corrected.
* Pre-existing neurological or severe psychiatric disorder (e.g. psychosis, bi-polar disorder).
* Diagnosed or suspected intellectual and developmental disability.
* No relative/friend/caregiver available to be recorded.
* Significant vision and/or hearing impairments that cannot be corrected.
* Pre-existing neurological or severe psychiatric disorder (e.g. psychosis, bi-polar disorder).
* Diagnosed or suspected intellectual and developmental disability.
Minimum Eligible Age
65 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
Sponsor Role
collaborator
NHS Greater Glasgow and Clyde
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danyal A Ansari, BA, MSc
Role: PRINCIPAL_INVESTIGATOR
NHSGGC and University of Glasgow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHSGGC
Glasgow, , United Kingdom
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United Kingdom
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Abraha I, Rimland JM, Lozano-Montoya I, Dell'Aquila G, Velez-Diaz-Pallares M, Trotta FM, Cruz-Jentoft AJ, Cherubini A. Simulated presence therapy for dementia. Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD011882. doi: 10.1002/14651858.CD011882.pub2.
Reference Type
BACKGROUND
Carver, C. S. (1997). Adult attachment and personality: Converging evidence and a new measure. Personality and Social Psychology Bulletin, 23(8), 865-883. https://doi.org/10.1177/0146167297238007
Reference Type
BACKGROUND
Clark CM, Ewbank DC. Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord. 1996 Spring;10(1):31-9.
Reference Type
BACKGROUND
Hazan C, Shaver P. Romantic love conceptualized as an attachment process. J Pers Soc Psychol. 1987 Mar;52(3):511-24. doi: 10.1037//0022-3514.52.3.511.
Reference Type
BACKGROUND
James, I. A. (2011). Understanding behaviours in dementia that challenge. Jessica Kingsley Publishers.
Reference Type
BACKGROUND
Tible OP, Riese F, Savaskan E, von Gunten A. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017 Aug;10(8):297-309. doi: 10.1177/1756285617712979. Epub 2017 Jun 19.
Reference Type
BACKGROUND
Venkatesh, V., Morris, M. G., Davis, G. B., & Davis, F. D. (2003). User acceptance of information technology: Toward a unified view. MIS Quarterly: Management Information Systems, 27(3), 425-478. https://doi.org/10.2307/30036540
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
294075
Identifier Type: OTHER
Identifier Source: secondary_id
GN21MH088
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study
NCT04828434
UNKNOWN
NA
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
NCT05748613
RECRUITING
NA
Piloting the Attention Training Technique for Post-Stroke Emotionalism
NCT06457126
NOT_YET_RECRUITING
NA
A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
NCT06668610
RECRUITING
NA
The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease
NCT06380725
NOT_YET_RECRUITING
NA
Cognitive Appraisals and Team Performance Under Stress in Simulated Trauma Care
NCT05083871
COMPLETED
Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia
NCT03638284
COMPLETED
NA
Multistimulation Group Therapy for Alzheimer's Disease
NCT01893398
COMPLETED
NA
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
NCT04171323
RECRUITING
NA
Implementation of Cognitive Stimulation Therapy
NCT04754932
COMPLETED
NA
Cognitive Stimulation Therapy - Effects on Cognitive and Functional Domains in Dementia - A Retrospective Data Review
NCT06932991
COMPLETED
Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease
NCT01847586
COMPLETED
NA
Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease
NCT04265378
COMPLETED
NA
'Go With the Flow': Effects of Mindful Self-Compassion in Psychiatric Rehabilitation
NCT04917081
COMPLETED
NA
Montessori-Based Activities for Elderly Persons With Dementia
NCT00079651
COMPLETED
PHASE2/PHASE3
Effects of an Empowerment-based Psycho-behavioral Program on Persons With Mild Cognitive Impairment
NCT04723667
COMPLETED
NA
tDCS and Cognitive Training for Mild Cognitive Impairment and Alzheimer's Dementia
NCT04507815
UNKNOWN
NA
Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment
NCT07332624
ENROLLING_BY_INVITATION
NA
Cognitive Behavioural Therapy of Early Dementia
NCT00735046
COMPLETED
The Effects of Noninvasive Brain Stimulation on Physical and Mental Functioning in Older Adults
NCT02436915
COMPLETED
NA
Cognitive Stimulation for Elderly Bipolar Patients
NCT04184375
RECRUITING
NA
Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment
NCT03784183
UNKNOWN
NA
Psychological Treatment to Support the Consequences of Cognitive Impairment
NCT04356924
RECRUITING
NA
Non-Pharmacological Treatments and Cognitive Impairment (NPT-CI2019)
NCT04118686
UNKNOWN
NA
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment
NCT01212692
COMPLETED
PHASE2